FDC Limited (BOM:531599)
India · Delayed Price · Currency is INR 376.45
+0.95 (0.25%)
At close: Jan 22, 2026
FDC Limited Employees
FDC Limited had 6,857 employees as of March 31, 2025. The number of employees increased by 198 or 2.97% compared to the previous year.
Employees
6,857
Change (1Y)
198
Growth (1Y)
2.97%
Revenue / Employee
3.03M INR
Profits / Employee
328.76K INR
Market Cap
60.09B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 6,857 | 198 | 2.97% |
| Mar 31, 2024 | 6,659 | 287 | 4.50% |
| Mar 31, 2023 | 6,372 | 36 | 0.57% |
| Mar 31, 2022 | 6,336 | 817 | 14.80% |
| Mar 31, 2021 | 5,519 | 111 | 2.05% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Jubilant Pharmova | 5,547 |
| CORONA Remedies | 4,508 |
| Granules India | 4,066 |
| Caplin Point Laboratories | 3,966 |
| Unichem Laboratories | 3,142 |
| Hikal | 2,062 |
| Gufic Biosciences | 1,484 |
| Procter & Gamble Health | 1,326 |
FDC Limited News
- 3 months ago - FDC receives ANDA approval from U.S. FDA for Pilocarpine Hydrochloride Ophthalmic Solution USP - Business Upturn
- 8 months ago - FDC shares drop over 3% as Q4 EBITDA falls 4.2% YoY to Rs 54 crore, net profit down 16.4% YoY - Business Upturn
- 1 year ago - FDC receives US FDA approval for Cefixime 400 mg tablets - Business Upturn
- 1 year ago - FDC shares surge 11%, leading gains in BSE Healthcare index - Business Upturn